XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.25.3

Net Loss Per Share Attributable to Common Stockholders | 9 Months Ended
--- | ---
Sep. 30, 2025
Earnings Per Share [Abstract] |
Net Loss Per Share Attributable to Common Stockholders | Net Loss Per Share Attributable to Common Stockholders The following table sets forth the calculation of basic and diluted net loss per share attributable to common stockholders during the three and nine months ended September 30, 2025 and 2024:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Net loss attributable to Nuvve Holding Corp. common stockholders | $ | (4,507,260) |  |  | $ | (1,649,843) |  |  | $ | (24,759,063) |  |  | $ | (12,327,595) |
Weighted-average shares used to compute net loss per share attributable to Nuvve common stockholders, basic and diluted | 18,557,638 |  |  | 666,894 |  |  | 8,954,465 |  |  | 567,486 |
Net Loss per share attributable to Nuvve common stockholders, basic and diluted | $ | (0.24) |  |  | $ | (2.47) |  |  | $ | (2.76) |  |  | $ | (21.72) |
The following outstanding shares of common stock equivalents were excluded from the calculation of the diluted net loss per share attributable to Nuvve common stockholders because their effect would have been anti-dilutive:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Stock options issued and outstanding | 5,902 |  | 6,834 |  |  | 5,902 |  | 6,834 |
Nonvested restricted stock issued and outstanding | — |  |  | — |  |  | — |  |  | — |
Public warrants | 7,188 |  | 7,188 |  |  | 7,188 |  | 7,188 |
Private warrants - February 2020 | 341 |  | 341 |  |  | 341 |  | 341 |
Private pre-funded warrants - July 2024 | — |  |  | 30,000 |  |  | — |  |  | 30,000 |
PIPE warrants | 3,384 |  |  | 3,384 |  |  | 3,384 |  | 3,384 |
2022 July Institutional/Accredited Investor Warrants | 10,000 |  |  | 10,000 |  |  | 10,000 |  |  | 10,000 |
Underwriter Warrant - February 2024 offering | 25,500 |  |  | 48,000 |  |  | 25,500 |  |  | 48,000 |
2024 February Institutional/Accredited Investor Warrants - series A | 480,000 |  |  | 480,000 |  |  | 480,000 |  |  | 480,000 |
2024 February Institutional/Accredited Investor Warrants - series B | — |  |  | 450,000 |  |  | — |  |  | 450,000 |
2024 February Institutional/Accredited Investor Warrants - series C | 30,000 |  |  | 480,000 |  |  | 30,000 |  |  | 480,000 |
2024 October Institutional/Accredited Investor Warrants | 1,623,501 |  |  | — |  |  | 1,623,501 |  |  | — |
2024 December Institutional/Accredited Investor Warrants | 277,780 |  |  | — |  |  | 277,780 |  |  | — |
2025 March Institutional/Accredited Investor Warrants | 6,483,939 |  |  | — |  |  | 6,483,939 |  |  | — |
2025 April Institutional/Accredited Investor Warrants | 4,980,253 |  |  | — |  |  | 4,980,253 |  |  | — |
2025 May Institutional/Accredited Investor Warrants | 24,102,223 |  |  | — |  |  | 24,102,223 |  |  | — |
2025 July Institutional/Accredited Investor Pre-funded Warrants | 477,145 |  |  | — |  |  | 477,145 |  |  | — |
2025 September Institutional/Accredited Investor Warrants | 649,393 |  |  | — |  |  | 649,393 |  |  | — |
May 2025 Consulting Warrants | 9,000,000 |  |  | — |  |  | 9,000,000 |  |  | — |
May 2025 Consulting Warrants | 2,000,004 |  |  | — |  |  | 2,000,004 |  |  | — |
Total | 50,156,553 |  | 1,515,747 |  | 50,156,553 |  | 1,515,747

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration